Difference between revisions of "Team:SCUT-China/Experiments"
Line 71: | Line 71: | ||
<img src="https://static.igem.org/mediawiki/2015/e/e2/2015-SCUT-China-experiment fig9.png" class="img" /> | <img src="https://static.igem.org/mediawiki/2015/e/e2/2015-SCUT-China-experiment fig9.png" class="img" /> | ||
<p class="smallIntroduction">Fig.9 cGMP concentration after cotransfection of alpha and beta subunit</p></div> | <p class="smallIntroduction">Fig.9 cGMP concentration after cotransfection of alpha and beta subunit</p></div> | ||
− | + | <div class="part"> | |
− | + | <h3 style="color:#00b4ed">3.PDE5A Silencing Device</h3> | |
− | + | <h2>Construction: </h2> | |
− | + | <p>Lentivirus vectors carrying three different PDE5A shRNA designs were created using the scarless golden gate assembly. The sequence to encode a EGFP fluorescent reporter was inserted after the Puro antibiotics-resistance gene, rather than directly after the shRNA gene, to avoid any potential influences on the function of the part.</p> | |
− | + | <p>Vector Map | |
− | + | <img src="https://static.igem.org/mediawiki/2015/e/e2/2015-SCUT-China-experiment-fig10png" class="img" /> | |
− | + | <p class="smallIntroduction">Fig.10 Lentivirus vector cointaing PDE5a silencing device | |
− | + | </p></p> | |
− | + | <h2>Confirmation of DNA Sequence:</h2> | |
− | + | <p>We confirmed the construction of shRNA gene, respectively, into Biobrick format flanking by required restriction sites (BBa_K1720003 and BBa_K1720005). </p> | |
− | + | <h2>Measurement of Gene Expression:</h2> | |
− | + | <p>We used RT-PCR to see whether expression of the PDE5A gene was suppressed by our shRNA devices. </p> | |
− | + | <img src="https://static.igem.org/mediawiki/2015/e/e2/2015-SCUT-China-experiment fig11.png" class="img" /> | |
− | + | <p class="smallIntroduction">Fig.11 PED5a transcription level after transfection with three different shRNA</p> | |
− | + | <p>The results showed that the expression of PDE5A was silenced by all three shRNA devices. </p> | |
− | + | <h2>Measurment of cGMP level:</h2> | |
− | + | <img src="https://static.igem.org/mediawiki/2015/e/e2/2015-SCUT-China-experiment fig12.png" class="img" /> | |
− | + | <p class="smallIntroduction"> Fig.12 cGMP concentration after treated with three different shRNA</p> | |
− | + | ||
− | + | <p>When we measured cellular cGMP levels, shRNA3 showed better potential. Therefore, we chose shRNA3 as our best PDE5A silencing device for further study (part number: BBa_K1720005).</p></div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<div class="part"> | <div class="part"> | ||
<h3 style="color:#08ade5">3.Hypoxia Responsive Promotor</h3> | <h3 style="color:#08ade5">3.Hypoxia Responsive Promotor</h3> |
Revision as of 17:59, 18 September 2015
Loading
Experiments & Results
1.SNP Treatment
In the preliminary experiments, we treated HEK 293 cells with 10umol/L sodium nitroprussiate (SNP), a NO donor, for different time periods. Cellular concentrations of cGMP were examined using a commercial Elisa Kit. As shown below, cellular concentration of cGMP increased after SNP treatment and peaked at 20 minutes. We used this condition as a positive control in our later experiments.
Fig.1 cGMP concentration after treated with 10umol/L SNP
2.sGC Overexpression
Construction:
Lentivirus vectors carrying the α or β subunits of sGC were created using the scarless golden gate assembly. The sequence encoding a fluorescent reporter was inserted after the antibiotics-resistance gene, rather than directly after the alpha3 and beta3 gene, to avoid any potential influences on the function of the part.
Vector Map of Alpha3 subunit
Fig.2 Lentivirus vector cointaing guanylate cyclase 1 alpha3 subunit gene
Vector Map of Bata3 subunit
Fig.3 Lentivirus vector cointaing guanylate cyclase 1 beta3 subunit gene
Confirmation of DNA Sequence:
We confirmed the construction of hGUY1A3 gene and hGUY1B3 gene encoding the α and β subunits of sGC, respectively, into Biobrick format flanking by required restriction sites (BBa_K1720000 and BBa_K1720001).
Transfection:
HEK293 cells were transfected with the designed devices. Vectors carrying α subunit of sGC was inserted with mCherry gene as a reporter (red) while vectors carrying β subunit of sGC was inserted with EGFP gene as a reporter (green). Both red and green fluorescence were observed under fluorescence microscope. The transfection appeared to be successful!
Fig.4 Red fluorescence signal after transfection of alpha3 subunit
Fig.5 Green fluorescence signal after transfection of beta3 subunit
Gene expression levels detection:
To examine gene expression of the key players in the cGMP metabolism pathway, we designed primers for hGUY1A3, hGUY1B3 and PDE5A. The house keeping gene GAPDH was used as an internal control. Results of RT-PCR and Real-time PCR were shown below. After transfection of the α and β subunits of sGC, the expression levels of α and β subunits were up-regulated. But the expression of PDE5A did not change significantly.
Fig.6 Transcription level after transfection with alpha3 and beta3 subunit
Fig.7 △CT vs GAPDH after transfection of alpha3 and beta3 subunit
Mesurement of sGC activity and cGMP concentration:
We next examined whether the overexpressed α and β subunits of sGC are functional. We used Elisa Kit to measure the sGC activity and cellular cGMP levels. Compared to empty vectors, transfection of the α and β subunits of sGC significantly increased sGC activity and cGMP level in HEK293 cells. Our sGC overexpressing devices worked successfully.
Fig.8 sGC activity after cotransfection of alpha and beta subunit
The result in Fig 8 indicated that sGC overexpression was successful! And we we used cGMP Elisa Kit to detect whether cGMP concentrantion increase at the same time.
Fig.9 cGMP concentration after cotransfection of alpha and beta subunit
3.PDE5A Silencing Device
Construction:
Lentivirus vectors carrying three different PDE5A shRNA designs were created using the scarless golden gate assembly. The sequence to encode a EGFP fluorescent reporter was inserted after the Puro antibiotics-resistance gene, rather than directly after the shRNA gene, to avoid any potential influences on the function of the part.
Vector Map
Fig.10 Lentivirus vector cointaing PDE5a silencing device
Confirmation of DNA Sequence:
We confirmed the construction of shRNA gene, respectively, into Biobrick format flanking by required restriction sites (BBa_K1720003 and BBa_K1720005).
Measurement of Gene Expression:
We used RT-PCR to see whether expression of the PDE5A gene was suppressed by our shRNA devices.
Fig.11 PED5a transcription level after transfection with three different shRNA
The results showed that the expression of PDE5A was silenced by all three shRNA devices.
Measurment of cGMP level:
Fig.12 cGMP concentration after treated with three different shRNA
When we measured cellular cGMP levels, shRNA3 showed better potential. Therefore, we chose shRNA3 as our best PDE5A silencing device for further study (part number: BBa_K1720005).
3.Hypoxia Responsive Promotor
Vector Map
Fig.13 Vecror containing hypoxia responsive CMV promotor and EGFP reporter
We designed a hypoxia responsive CMV promotor by inserting a hypoxia responsive element (HRE) to CMV promotor. We transiently transfected HEK293 cells with plasmids containing hypoxia-induced promotor and EGFP reporter. The positive control was transiently transfected with plasmids that contain CMV promoter and EGFP reporter. The control group was transiently transfected with plasmids that contain hypoxia responsive promotor and culture under aerobic situation. The experimental group was transiently transfected with plasmids that contain hypoxia responsive promotor and the cells were treated with sodium hyposulfite, an oxygen cleaner to cause hypoxia situation, for 2 hours.
Fig.14 EGFP signal under the control of CMV promotor
Fig.15 EGFP signal under the regulate of HRE in aerobic situation
Fig.16 EGFP signal under the regulate of HRE in hypoxia situation
From the results above, we can see that hypoxia responsive promotor still working under aerobic situation. So that this promotor is not a strict hypoxia responsive promotor as we expect.